CN102697999A - Externally applied Chinese medicine for treating rheumatism - Google Patents

Externally applied Chinese medicine for treating rheumatism Download PDF

Info

Publication number
CN102697999A
CN102697999A CN2012101772753A CN201210177275A CN102697999A CN 102697999 A CN102697999 A CN 102697999A CN 2012101772753 A CN2012101772753 A CN 2012101772753A CN 201210177275 A CN201210177275 A CN 201210177275A CN 102697999 A CN102697999 A CN 102697999A
Authority
CN
China
Prior art keywords
parts
chinese medicine
rhizoma
externally applied
applied chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012101772753A
Other languages
Chinese (zh)
Other versions
CN102697999B (en
Inventor
何圣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210177275.3A priority Critical patent/CN102697999B/en
Publication of CN102697999A publication Critical patent/CN102697999A/en
Application granted granted Critical
Publication of CN102697999B publication Critical patent/CN102697999B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an externally applied Chinese medicine for treating rheumatism. The externally applied Chinese medicine is prepared from the following raw material components in part by weight: 10 to 15 parts of frankincense, 10 to 20 parts of rhubarb, 5 to 10 parts of Chinese mugwort leaf, 5 to 10 parts of alpinia japonica, 10 to 15 parts of garden balsam stem, 5 to 15 parts of common clubmoss herb, 5 to 15 parts of obscured homalomena rhizome, 10 to 15 parts of safflower, 5 to 6 parts of notoginseng root, 6 to 10 parts of ligusticum wallichii, 1 to 3 parts of safflower oil, 5 to 15 parts of wild ginger, 5 to 10 parts of slenderstyle acanthopanax bark, 5 to 10 parts of rubia cordifolia and 1 to 3 parts of skimmia. The externally applied Chinese medicine can effectively alleviate pain of patients suffering from rheumatism, and is applicable to treatment of waist and leg rheumatalgia, cervical spondylosis, lumbar muscle strain, hyperosteogeny, left sequela due to trauma and the like and good in curative effect.

Description

A kind of external Chinese medicine of treating rheumatism
Technical field:
The present invention relates generally to the external field of Chinese medicines, relates in particular to a kind of external Chinese medicine of treating rheumatism.
Background technology:
Rheumatism is that one group of infringement joint, skeleton, muscle, blood vessel and relevant soft tissue or connective tissue are main disease, and wherein majority is an autoimmune disease.More hidden more than the morbidity course of disease is longer and slow, and has genetic predisposition mostly.
Rheumatism is a kind of acute or chronic body property ICT of common outbreak repeatedly, mainly involves heart, joint, central nervous system, skin and subcutaneous tissue.Clinical manifestation is main with carditis and arthritis, can be with heating, toxemia, erythra, subcutaneous nodule, chorea etc.Comparatively obvious with arthritis usually during acute attack.
Summary of the invention:
The object of the invention is exactly in order to remedy the defective of prior art, a kind of external Chinese medicine of treating rheumatism to be provided, and it can effectively alleviate rheumatisant's pain, good effect.
The present invention realizes through following technical scheme:
A kind of external Chinese medicine of treating rheumatism, it is characterized in that: the weight proportion of each raw material components is: Olibanum 10-15, Radix Et Rhizoma Rhei 10-20, Folium Artemisiae Argyi 5-10, Rhizoma alpiniae chinensis 5-10, Herba speranskiae tuberculatae 10-15, Herba Lycopodii 5-15, Rhizoma Homalomenae 5-15, Flos Carthami 10-15, Radix Notoginseng 5-6, Rhizoma Chuanxiong 6-10, safflower oil 1-3, Herba Asari 5-15, Cortex Acanthopancis 5-10, Cortex Ampelopsis Aconitifoliae Radicis 5-10, Caulis Et Folium Skimmiae 1-3.
A kind of external Chinese medicine of treating rheumatism, it is characterized in that: the weight proportion of each raw material components is: Olibanum 12, Radix Et Rhizoma Rhei 15, Folium Artemisiae Argyi 8, Rhizoma alpiniae chinensis 7, Herba speranskiae tuberculatae 13, Herba Lycopodii 12, Rhizoma Homalomenae 12, Flos Carthami 13, Radix Notoginseng 6, Rhizoma Chuanxiong 8, safflower oil 2, Herba Asari 8, Cortex Acanthopancis 8, Cortex Ampelopsis Aconitifoliae Radicis 7, Caulis Et Folium Skimmiae 2.
Advantage of the present invention is:
Of the present inventionly adopt safflower oil as guiding drug, promote each medical herbs infiltration, the Radix Notoginseng blood circulation promoting is delivered to disease institute with each medicine active ingredient; Prescription rationally has special effect, can effectively alleviate rheumatisant's pain; Adapt to waist, lower limb rheumatalgia, cervical spondylosis, lumbar muscle strain; Hyperosteogeny, and the sequela of leaving over because of wound etc., good effect.
The specific embodiment:
A kind of external Chinese medicine of treating rheumatism, the weight of each raw material components (g) proportioning is: Olibanum 12, Radix Et Rhizoma Rhei 15, Folium Artemisiae Argyi 8, Rhizoma alpiniae chinensis 7, Herba speranskiae tuberculatae 13, Herba Lycopodii 12, Rhizoma Homalomenae 12, Flos Carthami 13, Radix Notoginseng 6, Rhizoma Chuanxiong 8, safflower oil 2, Herba Asari 8, Cortex Acanthopancis 8, Cortex Ampelopsis Aconitifoliae Radicis 7, Caulis Et Folium Skimmiae 2.Above-mentioned all medicines are beaten powder, and safflower oil, Ovum Gallus domesticus album furnishing pasty state spread on the affected part, and once-a-day, two weeks is a course of treatment.
Model case:
1, yellow *, the woman, 51 years old, the patient lumbago occurred after because of fatigue, gradually to increasing the weight of, and the left lower extremity numbness occurred.Hospital's CT examination prompting: L4/5 lip appearance hyperosteogeny, L5/S1 degeneration of intervertebral disc, T12 compression fracture (old).Nearly two weeks sx, the lumbago of walking daytime is obvious, and left lower limb is numb, and the sleep of can not lying on the back night is met overcast and rainy symptom and is more increased the weight of.Through hospitalize 2 months, nothing was clearly better.Diagnosis: 1. lumbar vertebra hyperosteogeny.2. compression fracture (old).Use external Chinese medicine of the present invention in the time of 5 days symptom be clearly better numb disappearance the after 10 days, symptom complete obiteration during one and a half months, and accuse recovery from illness.
2, fourth *, the woman, 51 years old, the right knee joint of patient had an intense pain limitation of activity, local swelling, slight fever suddenly.Through local hospitalize 2 months, symptom did not subtract, after take the photograph the sheet prompting: " right knee joint hyperosteogeny ".Diagnosis: proliferative arthritis.With external Chinese medicine of the present invention after seven days right knee joint swelling heating be clearly better, symptom disappears basically behind the two weeks, the complete obiteration of one and a half months symptom.
3, Wu *, man, 75 years old.The patient suffered from both hands before 2 years numb, and symptom takes a turn for the better after the treatment transfusion.Nearly 1 year conscious total numbness, right half body is afraid of cold, and blood pressure is higher usually, sometimes cardiopalmus.Show through taking the photograph the sheet inspection: hyperosteogeny of cervical vertebra.Diagnosis: 1, hyperosteogeny of cervical vertebra.2, hypertension, coronary heart disease.With numb disappearance of external Chinese medicine medicine-feeding of the present invention.All diseases disappeared in continuous two months, did not have repeatedly.
4, take *, woman, 37 years old.Double knee joint pain appearred before 2 years, the time heavy when light, meet cold and increase the weight of.Can not walk about when heavy.Through taking the photograph the sheet prompting: the double knee joint hyperosteogeny.Diagnosis: proliferative arthritis.Double knee joint pain disappears after using external Chinese medicine two weeks of the present invention.Following up a case by regular visits to recovers does not have recurrence so far.
5, clock *, man, 60 years old; The patient does not have obvious inducement, and lower back dull pain 10 years to occur repeatedly surplus, caused the state of an illness to increase the weight of because of overworking in 2010, but also with dizzy, insomnia phenomenon; Multi-treatment does not have the improvement sign, comes the orthopaedics institute afterwards and finds on inspection: lumbar physiological-curvature exists, the waist muscular hypertonia; The straight lower limb of the other tenderness of waist 3,4,5 spinous process can't normally lift, through being diagnosed as chronic lumbar muscle strain.Use external Chinese medicine of the present invention double knee joint pain disappearance after 50 days.Following up a case by regular visits to recovers does not have recurrence so far.

Claims (2)

1. external Chinese medicine of treating rheumatism, it is characterized in that: the weight proportion of each raw material components is: Olibanum 10-15, Radix Et Rhizoma Rhei 10-20, Folium Artemisiae Argyi 5-10, Rhizoma alpiniae chinensis 5-10, Herba speranskiae tuberculatae 10-15, Herba Lycopodii 5-15, Rhizoma Homalomenae 5-15, Flos Carthami 10-15, Radix Notoginseng 5-6, Rhizoma Chuanxiong 6-10, safflower oil 1-3, Herba Asari 5-15, Cortex Acanthopancis 5-10, Cortex Ampelopsis Aconitifoliae Radicis 5-10, Caulis Et Folium Skimmiae 1-3.
2. a kind of external Chinese medicine of treating rheumatism according to claim 1, it is characterized in that: the weight proportion of each raw material components is: Olibanum 12, Radix Et Rhizoma Rhei 15, Folium Artemisiae Argyi 8, Rhizoma alpiniae chinensis 7, Herba speranskiae tuberculatae 13, Herba Lycopodii 12, Rhizoma Homalomenae 12, Flos Carthami 13, Radix Notoginseng 6, Rhizoma Chuanxiong 8, safflower oil 2, Herba Asari 8, Cortex Acanthopancis 8, Cortex Ampelopsis Aconitifoliae Radicis 7, Caulis Et Folium Skimmiae 2.
CN201210177275.3A 2012-06-01 2012-06-01 Externally applied Chinese medicine for treating rheumatism Expired - Fee Related CN102697999B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210177275.3A CN102697999B (en) 2012-06-01 2012-06-01 Externally applied Chinese medicine for treating rheumatism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210177275.3A CN102697999B (en) 2012-06-01 2012-06-01 Externally applied Chinese medicine for treating rheumatism

Publications (2)

Publication Number Publication Date
CN102697999A true CN102697999A (en) 2012-10-03
CN102697999B CN102697999B (en) 2014-07-09

Family

ID=46891246

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210177275.3A Expired - Fee Related CN102697999B (en) 2012-06-01 2012-06-01 Externally applied Chinese medicine for treating rheumatism

Country Status (1)

Country Link
CN (1) CN102697999B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006932A (en) * 2013-01-14 2013-04-03 张玉明 Medicinal liquor with Miao formula for effectively treating traumatic infection and traumatic treatment
CN104208443A (en) * 2014-09-01 2014-12-17 穆景信 External traditional Chinese medicine for treating rheumatism
CN104906267A (en) * 2015-06-10 2015-09-16 孔令刚 Traditional Chinese medicine for treating lumbosacral spinal cord pain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895642A (en) * 2005-07-12 2007-01-17 侯保君 Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895642A (en) * 2005-07-12 2007-01-17 侯保君 Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006932A (en) * 2013-01-14 2013-04-03 张玉明 Medicinal liquor with Miao formula for effectively treating traumatic infection and traumatic treatment
CN104208443A (en) * 2014-09-01 2014-12-17 穆景信 External traditional Chinese medicine for treating rheumatism
CN104906267A (en) * 2015-06-10 2015-09-16 孔令刚 Traditional Chinese medicine for treating lumbosacral spinal cord pain

Also Published As

Publication number Publication date
CN102697999B (en) 2014-07-09

Similar Documents

Publication Publication Date Title
CN105079757A (en) Traditional Chinese medicine composition for treating emphysema
CN103316141B (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN102697999B (en) Externally applied Chinese medicine for treating rheumatism
CN106039245A (en) External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof
CN103356953B (en) A kind of Chinese medicine composition for the treatment of lumbar muscle strain
CN102512645B (en) Traditional Chinese medicine composition for treating lumbago due to cold dampness
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN105796789A (en) Traditional Chinese medicine preparation for treating coronary heart disease
CN104587225A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN109498777A (en) Chinese medicine treats sick sinus syndrome and its preparation
CN102743608A (en) Traditional Chinese medicinal plaster for department of traumatology
CN103212041B (en) Chinese medicinal composition treating coronary heart disease
CN102008681B (en) Traditional Chinese medicine composition for treating chest pain and processing method thereof
CN101912566B (en) Traditional Chinese medicine for treating palpitation
CN103285108B (en) Chinese medicinal composition treating lumbago
CN102552843A (en) Medicament composite for curing osteoarthropathy
CN102283952A (en) Bone strengthening and marrow increasing Chinese patent medicine for treating bone diseases
CN102657737B (en) Medicament for treating acute gouty arthritis
CN102335203A (en) Miniature decoction
CN1895622A (en) Medicine for treating cervical spondylosis
CN105343510A (en) External traditional Chinese medicine composition for treating vulvar lichen sclerosus
CN103638230A (en) Chinese medicinal liquor for treating hyperostosis and preparation method thereof
CN1168476C (en) Capsule 'Qianggukang' for strengthening bone and its preparing process
CN104173930A (en) Traditional Chinese medicine composition for treating cold-damp lumbago
CN105687574A (en) Method for treating lumbar intervertebral disc protrusion through combined therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140709

Termination date: 20150601

EXPY Termination of patent right or utility model